Canada · Health Canada Drug Product Database
GLYCOBAL FORTIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 1507
- DIN
- 00250635
- Form
- Liquid
- Company as listed by source
- LAB NADEAU LTÉE, DIVISION OF TECHNILAB INC.
- Source status
- Cancelled Post Market (1999-09-28)
- Source last updated
- 2025-03-22
Source-listed ingredients
- THIAMINE HYDROCHLORIDE — .16 MG — per 1 ML
- PYRIDOXINE HYDROCHLORIDE — .034 MG — per 1 ML
- VITAMIN B2 — .12 MG — per 1 ML
- NICOTINAMIDE — 1 MG — per 1 ML
- CALCIUM GLYCEROPHOSPHATE — 8 MG — per 1 ML
- SODIUM GLYCEROPHOSPHATE — 6 MG — per 1 ML
- MANGANESE GLYCEROPHOSPHATE — 1 MG — per 1 ML
- GLYCEROPHOSPHATE POTASSIUM — 3.2 MG — per 1 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 100/250ml
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →